# Junta clínica — PT-pseudo_3f75ae876abe (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_3f75ae876abe",
  "pid": "PT-pseudo_3f75ae876abe",
  "task": 1,
  "psa": 16.8,
  "age": 69,
  "months": 1,
  "pirads": "5",
  "psad": 0.846,
  "psav": 3.33,
  "psap": 11.0,
  "vol": 19.86,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.87284654,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "91 kg",
    "height": "177 cm",
    "bmi": "29.0",
    "bp": "111/83 mmHg",
    "hr": "66 bpm",
    "smoking": "Current smoker (15 pack-yr)",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Jan 2025",
  "enc_ref": "Dr. L. Smits (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit."
    },
    {
      "s": "History",
      "t": "At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket \"None\". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute."
    }
  ],
  "occupation": "retired truck driver",
  "marital": "Married",
  "living": "Lives alone",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Ophthalmology — cataract review",
    "Endocrine — thyroid screening"
  ],
  "alcohol": "6 units / week",
  "exercise": "Limited mobility — chair-based exercises only",
  "ipss": "IPSS score: 16/35 (moderate LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "UMCG (Groningen)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_3f75ae876abe
Task: 1

Encounter: Urology - outpatient on 01 Jan 2025.
Referrer: Dr. L. Smits (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 69-year-old male
  - PSA: 16.8 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.846 ng/mL²
  - PSA velocity: 3.33 ng/mL/yr
  - Prior PSA: 11.0 ng/mL
  - Prostate volume: 19.86 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.87284654 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.

Vitals: weight 91 kg, height 177 cm, BMI 29.0, BP 111/83 mmHg, HR 66 bpm. Smoking: Current smoker (15 pack-yr).

Chief complaint: Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit.

History: At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket "None". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment.

Physical examination: DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute.

Patient info: retired truck driver; Married; Lives alone.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 16/35 (moderate LUTS).

Recent other appointments: Ophthalmology — cataract review; Endocrine — thyroid screening.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-CLASSIFIER

*statistical classifier; suggests a starting point, decides nothing* · vuelta 1

A classifier trained only to open the discussion, not to close it. Here is its bid.

SUGGESTION: BIOPSY   p(biopsy) = 0.85
  uncertainty  +/- 0.05 (95% CI 0.74-0.95); among patients it cannot tell apart the outcome was 0.62 of 1.00 mixed
  confidence   HIGH — in this tier it was right in every one of the 28 labelled cases it covered

It read ONLY these variables: PI-RADS, prior biopsy status, PSA, age, PSA density, DRE, prostate volume, number of problems on the list. Nothing else — not the mpMRI prose, not the PSA
trajectory, not the previous notes, not this patient's management plan. Values it could not
read for this patient: none.
Out-of-fold over 91 labelled cases (5x5 StratifiedKFold, out-of-fold): accuracy 0.714 against a
majority-class baseline of 0.615, AUC 0.789, F1(yes) 0.78.

The final call is the senior urologist's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like the classifier, I have read ONLY the visible panel — not the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory panel. Departing from me needs a specific
finding from a document somebody actually opened, named out loud. Not a restatement of the
panel numbers I already used.

## Intervención 5 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The guideline suggests that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy. It states, "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE CLASSIFIER'S BID DOES NOT SETTLE
The classifier's suggestion of biopsy is not sufficiently grounded because it ignores the guideline's emphasis on the PI-RADS threshold. The classifier's bid is blind to the specific threshold that the guideline sets for initiating the decision, which is the PI-RADS score, which is a variable the classifier could not read.

WHAT WE STILL NEED
the mpMRI prose - the report states the PI-RADS score is 5, which is $\ge 3$, which triggers the guideline recommendation for biopsy.
the PSA trend - the PSA velocity is $3.33 \text{ ng/mL/yr}$, which is a variable the guideline makes decisive regarding the risk stratification that the classifier could not read.
the previous notes - the notes state "Prior biopsy: None", which is a fact the guideline makes decisive regarding the decision pathway.
the laboratory results - the PSA density is $0.846 \text{ ng/mL}^2$, which is a variable the guideline makes decisive regarding the decision pathway.

## Intervención 6 — MODERATOR

*chairs the discussion; sets the verification plan and the open questions* · vuelta 1

This case hinges on whether we establish the full context from the MRI report and the PSA trend to confirm the guideline-driven decision.

Before anyone argues, this is what I want established, and by whom.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine the mpMRI prose regarding lesion characteristics.
  psa_trend (get_psa_trend) -> Determine the full PSA trajectory beyond the velocity.
  previous_notes (get_previous_notes) -> Confirm the management context, specifically the prior biopsy status.

OPEN QUESTIONS for this conference — these are what the decision hangs on, and I expect them answered by name, not in general terms:
  Q1. What does the mpMRI prose state regarding the lesion size, zone, and extraprostatic extension?
  Q2. What does the PSA trend show beyond the velocity, and what does the previous notes section confirm about the prior biopsy status?

## Intervención 7 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The mpMRI prose regarding lesion characteristics states: "T2-weighted sequences highlight a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm. Marginal capsular bulging is present without frank extraprostatic extension. Diffusion-weighted imaging exhibits marked signal restriction alongside correspondingly low ADC values. Dynamic contrast-enhanced sequences demonstrate early, focal enhancement localized to the lesion."
psa_trend
The full PSA trajectory beyond the velocity shows: {"date": "Nov 2022", "val": 2.8}, {"date": "Jul 2023", "val": 5.1}, {"date": "Apr 2024", "val": 9.2}, {"date": "Jan 2025", "val": 16.8}.
previous_notes
The previous notes section confirms the management context, specifically the prior biopsy status: {"date": "11 Jul 2023", "author": "Dr. L. Smits (GP)", "text": "Prostate-specific antigen concentrations rose from 7.4 ng/mL during November 2022 to 10.0 ng/mL on recent assessment. Digital rectal examination remained unremarkable. Lower urinary tract symptoms are moderate, absent any hematuria or unexplained weight loss."}

WHAT I DID NOT OPEN
I did not open the laboratory_results because the moderator did not specifically ask for it, and the key variables needed for the decision were covered by the other requested documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
mpMRI report states a PI-RADS 5 lesion, which is $\ge 3$.
previous_notes confirm the prior biopsy status was "None".
AGAINST sampling this patient now
nothing

WHERE THIS LEANS
The combination of a PI-RADS 5 finding and a prior biopsy status of "None" strongly supports the guideline-driven recommendation for biopsy.
LEAN: biopsy

## Intervención 8 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The registrar successfully answered both open questions by retrieving the `radiology_report` and `psa_trend` for Q1 and Q2, respectively, and confirmed the prior biopsy status via `previous_notes` for Q2.

ALIGNMENT WITH THE CLASSIFIER
The retrieved evidence aligns with the EXPERT-CLASSIFIER's suggestion of BIOPSY because the mpMRI report states a PI-RADS 5 lesion ($\ge 3$), and the previous notes confirm the prior biopsy status was "None," which supports the cohort criterion.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What does the mpMRI prose state regarding the lesion size, zone, and extraprostatic extension? Answered by the registrar via the `radiology_report`: "T2-weighted sequences highlight a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm. Marginal capsular bulging is present without frank extraprostatic extension."
Q2. What does the PSA trend show beyond the velocity, and what does the previous notes section confirm about the prior biopsy status? Answered by the registrar: The PSA trend shows values of 2.8 (Nov 2022), 5.1 (Jul 2023), 9.2 (Apr 2024), and 16.8 (Jan 2025), and the previous notes confirm the prior biopsy status was "None."

WHAT CARRIES WEIGHT, AND WHY
The two most relevant variables are the PI-RADS score (5) because it directly triggers the EAU guideline recommendation for biopsy, and the prior biopsy status ("None") because the guideline specifically mentions this as a factor in risk stratification. The PSA trend is also relevant as it shows a significant rise over time, supporting the clinical concern. The guideline does not explicitly support any variable the room has been leaning on, as the evidence strongly supports the biopsy path.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy based on the strong alignment between the PI-RADS 5 finding and the prior biopsy status of "None," as this meets the threshold set by the EAU guideline.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 9 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

I recommend biopsy because the mpMRI demonstrated a PI-RADS 5 lesion, which meets the guideline threshold for sampling. This finding is strongly supported by the prior biopsy status being 'None', which is a decisive factor in risk stratification. The PSA trend also shows a significant rise, further supporting the need for tissue diagnosis.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=important, pirads=decisive
Documents this conference opened: radiology_report, psa_trend, previous_notes
